Cleared Traditional

K252520 - SEFRIA™ Hydrocodone Oral Fluid (FDA 510(k) Clearance)

Sep 2025
Decision
31d
Days
Class 2
Risk

K252520 is an FDA 510(k) clearance for the SEFRIA™ Hydrocodone Oral Fluid. This device is classified as a Enzyme Immunoassay, Opiates (Class II - Special Controls, product code DJG).

Submitted by Immunalysis Corporation (Pomona, US). The FDA issued a Cleared decision on September 11, 2025, 31 days after receiving the submission on August 11, 2025.

This device falls under the Toxicology FDA review panel. Regulated under 21 CFR 862.3650.

Submission Details

510(k) Number K252520 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 11, 2025
Decision Date September 11, 2025
Days to Decision 31 days
Submission Type Traditional
Review Panel Toxicology (TX)
Summary Summary PDF

Device Classification

Product Code DJG — Enzyme Immunoassay, Opiates
Device Class Class II - Special Controls
CFR Regulation 21 CFR 862.3650

Similar Devices — DJG Enzyme Immunoassay, Opiates

All 23
Labcorp Fentanyl Urine Visual Test
K252684 · Medtox Diagnostics, Inc. · Jan 2026
LZI Buprenorphine II Enzyme Immunoassay
K253082 · Lin-Zhi International, Inc. · Jan 2026
Healgen® AccuFluor Fentanyl Fluorescence Immunoassay (FIA)Test Kit - Qualitative
K251972 · Healgen Scientific, LLC · Aug 2025
LZI Fentanyl III Enzyme Immunoassay
K251634 · Lin-Zhi International, Inc. · Jun 2025
CEDIA Heroin Metabolite (6-AM) Assay
K231007 · Microgenics Corporation · Sep 2023
Emit® II Plus Buprenorphine Assay
K221605 · Siemens Healthcare Diagnostics, Inc. · Jul 2023